<DOC>
	<DOC>NCT01322633</DOC>
	<brief_summary>The primary objective is to assess whether the risk of gastric cancer is increased in pantoprazole users compared to users of other proton pump inhibitors.</brief_summary>
	<brief_title>Risk of Cancer Among Pantoprazole Users</brief_title>
	<detailed_description>All subjects who met the inclusion criteria were included in the study.</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients who have used pantoprazole or other proton pump inhibitors, enrollment in the health maintenance organization for at least 6 months, age 18 years or older. Use of any proton pump inhibitor before study entry, any cancer diagnosis recorded in the medical history, diagnosis of ZollingerEllison Syndrome in medical history.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pantoprazole</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>digestive system cancer</keyword>
	<keyword>cancer</keyword>
</DOC>